U.S. Markets open in 8 hrs 44 mins

Antares Pharma, Inc. (ATRS)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.01+0.06 (+2.03%)
At close: 4:00PM EDT
People also watch
ACRXCPRXGALEATHXAMRN
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue52,222.04645,658.126,501.665
Cost of Revenue28,816.76619,457.68311,236.695
Gross Profit23,405.2826,200.41715,264.97
Operating Expenses
Research Development21,126.93619,731.56418,638.016
Selling General and Administrative26,394.80426,930.83231,740.249
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-24,116.46-20,461.979-35,113.295
Income from Continuing Operations
Total Other Income/Expenses Net-122.344-21.867-13.42
Earnings Before Interest and Taxes-24,238.804-20,483.846-35,126.715
Interest Expense---
Income Before Tax-24,238.804-20,483.846-35,126.715
Income Tax Expense10017525
Minority Interest---
Net Income From Continuing Ops-24,338.804-20,658.846-35,151.715
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-24,338.804-20,658.846-35,151.715
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-24,338.804-20,658.846-35,151.715